Close
Almac
Achema middle east

News

AI Boost In Pharma: Enhancing Care With Human-Led Solutions

Digital tools are changing how the pharmacy business can meet the needs of consumers and healthcare workers (HCPs). The key is to use a human led, AI-powered method that blends the best of human knowledge and cutting edge artificial...

PhotonPharma Secures $2.5 Million in Seed Funding to Advance Clinical Trial for Ovarian Cancer Treatment

PhotonPharma, a cutting-edge biopharmaceutical company based in Fort Collins, Colorado, is pleased to announce the successful closing of a $2.5 million seed financing round. This vital funding will support the Phase I clinical trial of Innocell™, an innovative therapy...

BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases

BioVaxys Technology Corp. highlights the potential of its novel lipid-in-oil delivery platform, DPX™, across multiple infectious disease studies and announces its plans for partnering and further development. BioVaxys' DPX™ technology is a patented delivery platform that can incorporate a range...

Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program

Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen's DNA-encoded...

Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent

Bora Pharmaceuticals Co., Ltd., a a global leader in pharmaceutical manufacturing announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics...

PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Aug. 21, 2024 that its Bedford, NH campus successfully completed the multi-agency inspection process of the International Coalition of Medicines Regulatory Authorities...

FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples existing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »